Back

Development of an enzyme-linked immunosorbent assay for versikine detection and first analyses in human cardiovascular disease

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Decoding heart failure: novel biomarkers and artificial intelligence Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Simon Andrup

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Machine learning phenotyping of HefpEF :a systematic review and meta analysis of validation cohorts with external generalizability assessment
Doctor J. Gohri (New Delhi, IN)
Abstract
Presentation thumbnail
Soluble transferrin receptor and hepcidin but not standard iron biomarkers are reliable prognostic biomarkers in heart failure
Doctor L. Lanser (Innsbruck, AT)
Abstract
Presentation thumbnail
BNP trajectory and the risk of heart failure hospitalisation in stage 2 CKM syndrome
Doctor K. Teramoto (Osaka, JP)
Abstract
Presentation thumbnail
Plasma E-selectin and C-C motif chemokine ligand 3 differentiate pulmonary arterial hypertension from other forms of pulmonary hypertension and healthy controls
Doctor S. Ahmed (Helsingborg, SE)
Abstract

Access the full session

Session thumbnail
Decoding heart failure: novel biomarkers and artificial intelligence

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Significant correlation between endothelin-1 levels in human plasma from coronary arteries measured by enzyme linked immunosorbent assay and olink proteomics proximity extension assay
1 September 2025
thumbnail
Congress Presentation
Regional levels of tenascin- C in patients with heart failure and atrial fibrillation
22 May 2023
thumbnail
Congress Presentation
Biomarkers for endocardial vegetations diagnosis and prognosis: preliminary data from the BEEP STUDY
13 December 2025
thumbnail
Congress Presentation
Collagen VI and endotrophin: potential extracellular matrix targets to attenuate adverse cardiac remodeling post-infarction
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources